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Abstract Apoptosis, necrosis, or autophagy—it is the
mode of cell demise that defines the response of surround-
ing cells and organs. In case of one of the most toxic
substances known to date, cadmium (Cd), and despite a
large number of studies, the mode of cell death induced is
still unclear. As there exists conflicting data as to which cell
death mode is induced by Cd both across various cell types
and within a single one, we chose to analyse Cd-induced
cell death in primary human endothelial cells by investi-
gating all possibilities that a cell faces in undergoing cell
death. Our results indicate that Cd-induced death signalling
starts with the causation of DNA damage and a cytosolic
calcium flux. These two events lead to an apoptosis sig-
nalling-related mitochondrial membrane depolarisation and
a classical DNA damage response. Simultaneously, autop-
hagy signalling such as ER stress and phagosome formation
is initiated. Importantly, we also observed lysosomal
membrane permeabilization. It is the integration of all sig-
nals that results in DNA degradation and a disruption of the
plasma membrane. Our data thus suggest that Cd causes the
activation of multiple death signals in parallel. The geno-
type (for example, p53 positive or negative) as well as other
factors may determine the initiation and rate of individual
death signals. Differences in the signal mix and speed may
explain the differing results recorded as to the Cd-induced
mode of cell death thus far. In human endothelial cells it is
the sum of most if not all of these signals that determine the
mode of Cd-induced cell death: programmed necrosis.
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Introduction
Cadmium (Cd) is a toxic heavy metal and pollutant which
is ubiquitously distributed in our environment. Human
uptake occurs mainly by diet and exposure to cigarette
smoke [1, 2]. The primary target organs in the human
body are the kidneys, liver, testes, bones [1–5] and those
of the cardiovascular system [6]. Furthermore, Cd is also
known to be carcinogenic within different organs and
tissues, which has led the International Agency for
Research on Cancer to classify Cd as a Group I human
carcinogen [7, 8].
Based on the variety of target organs of Cd-induced
toxicity, a mass of in vitro data exists investigating the
effect of Cd on different cell types. Further, Cd triggers
different pathways within different cell types, rendering the
landscape even more complex. In this respect one of the
most useful examples is in Cd-induced cell death. In gen-
eral and based upon knowledge gained thus far cell death
may be classified into apoptosis, necrosis and autophagy,
whereby, above all, detailed molecular and biochemical
analyses are indicative of an alternative classification. In
this regard, the morphological system of classification is
being replaced by a functional system based on the
demonstration of detailed signalling pathways and
involved molecules [9]. Further adding to the complexity
of signalling pathways in response to Cd toxicity, outcome
is also dependent on Cd concentration; this may serve to
explain some of the contradictory reports presently existing
as to Cd-induced cell death. Interestingly, a review of lit-
erature revealed that even within one cell type different
pathway outcomes are described. Important examples of
contradictory findings regarding the Cd-induced cell death
signals and final outcome are found in experiments per-
formed upon kidney cells. Different in vitro studies have
revealed highly diverse signalling pathways, ranging from
caspase-independent [10] to caspase-dependent [11–14]
apoptosis, although nearly all apoptotic cell death signals
have in common an attendant impairment of the mito-
chondria. Additionally, several studies performed upon
kidney cells have demonstrated autophagic signals [15], as
well as signals for apoptosis and necrosis [16–18] or
apoptosis and autophagy [19, 20] within the same cell type.
Similarly, Lemaire et al. has reported caspase independent
Cd-induced cell death in liver cells [21], whereas within
the same cells, Oh et al. and Lasfer et al. provided evidence
of caspase-dependent apoptotic signals [22, 23].
In addition to accumulating in known tissues such as the
kidney, liver and bone, increased Cd concentrations were
detected in blood serum and aortic walls (up to 20 lM) [6]
of young smokers [24]. Beyond that, we and others have
demonstrated that Cd is a risk factor for the development of
atherosclerosis leading to fatal cardiovascular outcomes
[24–29]. Thus, in addition to activating the cell death
machinery [30–32] Cd exerts further effects on endothelial
cells. These effects include increased expression of the
adhesion molecules ICAM-1 [33, 34] and VCAM-1 [35]
which possibly facilitates the adhesion and trans-endothe-
lial migration of leucocytes leading to vascular
inflammation. Furthermore, Cd treatment is known to
attenuate the production of the essential vascular signalling
molecule nitric oxide (NO) [36–38] thereby reducing the
responsiveness of the vascular wall to essential signals. In
2000, Liu et al. demonstrated the genotoxic effect of Cd in
endothelial cells as a result of the production of reactive
oxygen radicals (ROR). [39] Cd-caused endothelial dys-
function is triggered by defective migratory ability of
endothelial cells and inhibited angiogenesis. [40, 41]
Ultimately, exposure of endothelial cells to Cd once again
initiates cell death signals with inconsistent findings
regarding the final fatal outcome. Kim et al. and Jung et al.
have postulated a caspase-dependent apoptotic signalling
pathway [30, 31] whereas Wolf et al. detected evidence of
cell membrane damage and therefore necrosis [32].
Recently, a study conducted by Dong et al. revealed a
novel pathway, whereby Cd-induced apoptotic signals are
inhibited and rather autophagy is induced [42]. The process
of Cd-induced endothelial cell death becomes further
complicated still, as we have now shown that Cd triggers a
programmed form of necrotic cell death accomplished by
the rupture of lysosomes [43].
Taken together, the results concerning Cd-induced cell
death signalling in endothelial cells are inconsistent. Pro-
ceeding from the results of a previous study by our group
[43] in which we analysed the effect of Cd as a new risk
factor for atherosclerosis development on endothelial cells,
the present study aims to provide a highly detailed
description of cell death signals within Cd-exposed
endothelial cells, from Cd uptake over initiated signalling




A detailed description of the isolation of endothelial cells
(HUVECs) of umbilical cords is described elsewhere [44].
The isolation and analyses of the used cells is approved by
the Ethics Committee of the Medical University of Vienna
(EK Nr. 1183/2012). Endothelial cells were cultured on
gelatine-coated (Sigma Aldrich, Austria) polysterene culture
flasks (TPP, Switzerland) in a specialised endothelial cell
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culture medium (EGM-2, Lonza). Prior to each experiment,
the medium was replaced by fresh medium containing the
indicated Cd concentrations. The following inhibitors were
used: 50 lM calpain-inhibitor III (MDL 28170, Sigma
Aldrich, Germany), 2 mM 3-Methyladenine (3MA; M9281,
Sigma Aldrich, Germany) and 50 lM 2-Aminoethyl
diphenylborinate (2APB, D9754, Sigma Aldrich, Germany),
100 lM Dantrolene (550-072-M050, Eubio) and 10 lM
BAPTA (BML-CA411-0025, Enzo Lifesciences).
Comet assay
To detect DNA damage in endothelial cells after Cd treatment,
a Comet-assay was performed according to the manufac-
turer’s instructions (Trevigen, Cat.No.: #4250-050-K).
Generation of stable BCL-XL OE cells as well as p53
KD HUVECs
Generation of stable BCL-XL OE cells and knock-down of
p53 in endothelial cells was performed as previously
described [43]. Monitoring of stable p53 KD and BCL-XL
OE in endothelial cells is shown in the Supplemental
Material, Figure S10, S11.
Quantification of intracellular Ca21 concentration
After the treatment, cells were incubated with 1 lM FLUO
3/AM (Calbiochem, # 343242), a cell-permeable Ca2?
indicator that exhibits an increase in fluorescence upon Ca2?
binding. Increase in fluorescence intensity after Cd treatment
was detected using flow cytometry analysis (FACS Canto II,
BD Biosciences) and quantified as change in the intensity as
compared to the control level. We used BAPTA-AM (BML-
CA411-0025, Enzo Life Sciences) at a concentration of
10 lM as a sensitive intracellular Ca2? chelator.
Detection of intracellular Cd
After treatment the cells were handled as indicated by the
manufacturer’s instructions (LeadmiumTM Green AM Dye
for intracellular Detection of Lead and Cadmium; Life
Technologies, Cat.No.: 10024) and analysed by flow
cytometry (FACS Canto II, BD Biosciences, Germany).
Detection of changes in the mitochondrial
membrane potential and staining of mitochondria
After the treatment, cells were enzymatically detached,
washed with PBS and incubated with 5 lM JC-1 according
to the manufacturer’s instructions (Molecular Probes, Aus-
tria). Analysis and quantification of changes in the
fluorescence intensity, indicating depolarised mitochondria,
was performed using a FACS Canto II (BD Biosciences,
Germany). Tracking of the cellular distribution of mito-
chondria in Cd-treated cells as compared to the control cells
was performed using MitotrackerRed FM and according to
the manufacturer’s instructions (Life Technologies, Molec-
ular Probes).
Tracking of lysosome stability
Labelling of lysosomes was performed as previously descri-
bed in Messner et al. [43]. Endothelial cells with or without an
inhibitor and p53 KD cells were incubated with 15 lM Cd and
30 lM Cd, respectively for the indicated times.
Western blot analyses
Whole protein extracts from Cd-treated and control cells were
obtained by incubation of detached cells in a triple detergent
lysis buffer (50 mM Tris-Chloride, 150 mM Sodium Chlo-
ride, 0.02 % Sodium Azide, 0.1 % SDS, 1 % Nonident P-40,
0.5 % Sodium Deoxycholate, 5 lg/ml Aprotinin, 1 lg/ml
Leupeptin, 1 lg/ml Pepstatin and 1 mM ABESF). Cells were
lysed by repeated freezing and thawing and subsequent son-
ication. After determination of protein concentration, equal
amounts of proteins were separated (20 lg) on SDS–poly-
acrylamide gels and subsequently transferred onto a
nitrocellulose membrane (Schleicher and Schuell, Germany).
The primary antibody used was anti-phospho S51 eIF2 alpha
(ab47769; Abcam, UK; dilution: 1:750). The secondary
antibody used was goat anti-rabbit IgG HRP-conjugate
(#31460, Thermo Scientific, Austria). To control loading of
equal protein amounts, membranes were stained with Ponceau
S and the GAPDH expression (ab9485; Abcam, UK, dilution
1:2500) was analysed using Western blotting (secondary
antibody: goat anti-rabbit IgG HRP-conjugate #31460,
Thermo Scientific, Austria). Quantification of bands was
performed using ImageJ software (National Institute of
Health) and the ratios of the band intensities (GAPDH to
specific eIF2 alpha S51) were calculated.
Quantification of cell death
For the analysis and quantification of Cd-induced cell
death, different methods were used. Annexin V/PI staining
served for the discrimination of apoptotic and necrotic cell
death. The staining of the cells was performed as described
in Bernhard et al. [44]. And the quantification was per-
formed using a flow cytometry device (FACS Canto II, BD
Biosciences, Germany). Annexin V and PI positive cells
were summarised and quantified compared to correspond-
ing controls to display all dead cells. Furthermore, the
effect of Cd on the cell membrane integrity of endothelial
cells was analysed by the quantification of lactate
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dehydrogenase (LDH) release using the LDH cytotoxicity
kit II (Biovision) according to the manufacturer’s instruc-
tions. Released LDH was quantified as compared to the
LDH content of the entire cell.
Detection and quantification of cellular DNA content
and PI staining
After permeabilization of cell membranes with 1 mg/ml of
saponin, the DNA was stained with PI and the DNA content
was then quantified by flow cytometry (FACS Canto II, BD
Biosciences, Germany). Moreover, cells were cultivated in
Lab Teks (BD Biosciences) and treated with 15 and 30 lM
Cd, respectively for 48 h. After fixation with 4.5 %
paraformaldehyde, cells were permeabilized with 0.2 %
Triton X-100 and cell nuclei were stained with PI (1 mg/ml).
Scanning electron microscopic images of Cd-treated
endothelial cells
Fixation of treated cells was performed using 2.5 % glu-
taraldehyde. Thereafter, cells were dehydrated in a graded
ethanol series (70, 90, 100, 100, 100 %, and acetone), des-
iccated by critical point drying (Emitech K850; Quorum
Technologies LTD, West Sussex, UK), mounted, sputtered
with gold–palladium (Polaron CA 508; Fisons Instruments,
Mainz-Kastel, Germany) and examined with a JEOL JSM—
5400 scanning electron microscope (Eching, Germany).
Statistical analysis
Primary data were tested for a Gaussian distribution and
equality of variances. Equal distributed data were subjected
either to student’s t Test or to one-sided ANOVA. Statis-
tical analyses were performed using IBM SPSS Statistics
20.0 (SPSS Inc. USA).
Results
Chelation of Cd by EGTA prevents toxicity and Cd
treatment induces DNA strand breaks in endothelial
cells
Pre-treatment of Cd incubated endothelial cells with the
Ca2? (Calcium) chelator EGTA (ethylene glycol tetra-
acetic acid) significantly reduces the toxicity of this heavy
metal. Quantification of flow cytometry-based Annexin
V/Propidium Iodide (PI) staining revealed a significant
inhibition of Cd-induced cell death by increasing EGTA
concentrations after treatment with 15 or 30 lM Cd
(Fig. 1a). To analyse the genotoxic effects of Cd on
endothelial cells, a Comet-Assay was performed. Figure 1c
shows representative images of the Comet Assay from both
control and Cd-treated cells after 12 h. The amount of
Comet positive cells after Cd treatment was quantified and
the results are displayed in Fig. 1b. Massive DNA strand
breaks are observed after treatment with 15 or 30 lM Cd.
However, no influence of Cd on the cell cycle could be
observed (Supplemental Material, Figure S5).
Cd treatment provokes an increase in intracellular
Ca21 concentration
In addition to the rapid genotoxic effect, Cd provokes a
significant increase in intracellular Ca2? concentration,
already detectable after 1 h of incubation (Supplemental
Material, Figure S1). Furthermore, the involvement of the
Ca2? sensitive non-lysosomal cysteine protease calpain
was analysed by the usage of the calpain I and II inhibitor
(MDL 28170) showing a significant inhibition of Ca2? flux
in cells treated with 15 lM Cd, but no effect in cells treated
with 30 lM Cd after 24 h (Fig. 2b). To rule out the role of
p53 in Cd-induced cell death as previously suggested [43],
we generated p53 KD endothelial cells to address the
question of whether Cd-induced DNA breaks result in a
p53-dependent cell death response. Although p53 is
involved in the Cd-induced cell death pathway, a knock-
down of p53 was not able to inhibit the intracellular Ca2?
flux induced by Cd after 24 h (Fig. 2a).
Involvement of BCL-XL in Cd-induced Ca2? flux was
analysed using endothelial cells overexpressing this anti-
apoptotic protein, and Fig. 2c shows that this overexpression
is highly efficient in inhibiting Ca2? flux. To test the
hypothesis that Cd treatment induces a substantial release of
Ca2? from the endoplasmatic reticulum (ER), 2APB (2-
Aminoethoxydiphenyl borate) was used to inhibit InsP3
(Inositol 1,4,5-triphosphate)-mediated Ca2? release. Flow
cytometry-based analyses uncovered that 2APB incubation
is not able to inhibit Cd-induced Ca2? flux entirely, but does
so significantly as observed 24 h after treatment with 30 lM
(Fig. 2d). Referring to the controversially discussed speci-
ficity of 2APB as restricted to ER Ca2? pumps, we analysed
the effect of this inhibitor upon the cellular Cd uptake.
Leadmium-dye-based intracellular Cd quantification indi-
cates that 2APB significantly inhibits Cd uptake (Fig. 2e).
Cd treatment induces mitochondrial membrane
depolarisation and changes in the mitochondrial
distribution
Further in-depth characterisation of Cd-induced cell death
signals uncovered an involvement of the mitochondria.
Treatment of endothelial cells with 15 lM Cd as well as
30 lM Cd provokes a significant depolarisation of the
mitochondria over an incubation period of 72 h (Fig. 3). As
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calpains are also present in the mitochondria, the effect of
the calpain inhibitor on mitochondrial depolarisation was
tested. Figure 3a shows that the calpain inhibitor was
efficient in inhibiting the depolarisation after treatment
with 15 and 30 lM Cd over a period of 72 h. A
stable overexpression of the anti-apoptotic protein BCL-
XL was able to inhibit mitochondrial depolarisation
although the effect is less pronounced as compared to the
effect of the calpain inhibitor (Fig. 3b). A similar inhibi-
tory effect on mitochondrial depolarisation was detected in
cells with a stable p53 knock-down (KD) (Fig. 3c). Fur-
thermore, chelation of Ca2? by the chelating agent BAPTA
completely inhibits mitochondrial depolarisation induced
by 15 lM Cd after 48 h, but showed no effect after treat-
ment with 30 lM Cd or after a longer Cd exposure (up to
72 h). However, this effect can be explained by the cell-
toxic effect of BAPTA treatment itself (Fig. 3d). A detailed
analysis of mitochondrial structure revealed severe Cd-
dependent effects on mitochondrial mass (Fig. 3e, 15 lM)
and integrity (Fig. 3e, 30 lM). This strongly suggests that
Cd-induced cell death is mediated by mitochondria
integrity.
Lysosomal membrane permeabilization
and induction of autophagy signals are
characteristic of death signalling in Cd-treated
endothelial cells
As already reported by our group, Cd treatment of
endothelial cells induces autophagy signals (namely, an
increase in LC3 I to LC3 II ratio). As the lysosomes are
involved in autophagy signalling, we analysed stability of
these organelles using flow cytometry techniques which
show a strong Cd-dependent disruption of lysosome
integrity (Fig. 4). Moreover, Fig. 4a shows that the
stable knock-down of p53 is able to completely inhibit
lysosomal degradation after treatment with 15 lM Cd over
a time period of 96 h as well as in cells incubated with
30 lM Cd over 72 h. In contrast, inhibition of calpain
protease or autophagy (3MA) failed to exert lysosome-
protective characteristics (Supplemenatl Material, Fig-
ure S6 A, B). In response to the unfolded protein response
(UPR) (also a part of autophagy signalling) within the ER,
the function of eukaryotic initiation factor eIF2 alpha is
inhibited by phosphorylation. Western blot-based analyses
showed a phosphorylation of eIF2 alpha in response to Cd
treatment (Fig. 4b).
Classical AnnexinV/PI based flow cytometry
analyses reveal apoptosis as the prevailing mode
of Cd-induced cell death
Flow cytometry-based analyses uncovered apoptosis as the
prevailing cell death mode. After 72 h of treatment with
15 lM Cd, nearly equal numbers of cells are dying by
apoptosis and necrosis. Treatment with a higher Cd con-
centration of 30 lM induces a marked increase in the
amount of apoptotic cells. Prolonged treatment with
15 lM Cd over a time period of 96 h enhances necrotic
and, to a greater extent, apoptotic cell death (Fig. 5a).
Fig. 1 Inhibition of Cd toxicity by EGTA and the effect of Cd on
endothelial DNA. a Shows the quantification of Cd-induced cell death
(Annexin V/PI staining) after pre-treatment of cells with increasing
EGTA concentrations. (b) Quantification of Comet-tail positive
endothelial cells after treatment with 15 and 30 lM Cd for 12 h.
(c) Representative images of cell nuclei stained with SYBR green. All
experiments were performed in triplicates and were repeated at least
three times. Results depict the mean ± standard deviation. Asterisks
indicate significant differences compared to the corresponding control
(*p\ 0.05; **p\ 0.01, ***p\ 0.001) and hash signs indicate
significant differences between the groups (#p\ 0.05; ##p\ 0.01);
ns not significant
Cadmium overkill: autophagy, apoptosis and necrosis signalling in endothelial cells exposed… 1703
123
Figure 5b depicts the calpain inhibitor’s ability to reduce
the amount of dead cells after treatment with 15 and
30 lM Cd for 72 h. Likewise, the stable knock-down of
p53 is able to prevent Cd-induced death over 72 h, where
the effect of the knock-down is stronger than the effect of
the calpain inhibitor (Fig. 5c). Overexpression of the anti-
apoptotic protein BCL-XL has only a minor inhibiting
effect upon cell death, yet the effect is nonetheless sta-
tistically significant at both concentrations (Fig. 5d).
Neither inhibition of autophagy with 3MA (Fig. 5e)
nor energy supplementation (Supplemental Material,
Figure S9 A–C) protects cells treated with 15 lM Cd.
However, we observed an almost-significant increase of
viability in 30 lM Cd-treated cells (p = 0.079; Fig. 5e).
Based on the controversial results obtained with 2APB
(partial inhibition of Ca2? flux and inhibition of Cd
uptake), the effect of this inhibitor on Cd-induced cell
death was assessed. 2APB was able to completely inhibit
death of cells treated with 15 lM Cd and showed the most
potent cell death inhibitory effect in cells treated with
30 lM Cd as compared to all other inhibitors, knock-
downs and over-expressions (Fig. 5f).
Fig. 2 Cd induced increase in
cytosolic Ca2? concentration.
a–d show flow cytometry-based
quantifications of intracellular
Ca2? concentration after Cd
treatment of endothelial cells for
the indicated times. The effect
of p53 KD (a), the incubation
with calpain inhibitor (b), over-
expression of BCL-XL (c), and
of the incubation with 2APB
(d) on cytosolic Ca2?
concentration is also depicted.
e Shows flow cytometry-based
analyses of the effect of 2APB
on endothelial Cd uptake after
96 h. All experiments were
performed in triplicates and
were repeated at least three
times. Results depict the
mean ± standard deviation.
Asterisks indicate significant
differences compared to the
corresponding (*p\ 0.05;
**p\ 0.01) and hash signs
indicate significant differences
between the groups (#p\ 0.05;
##p\ 0.01)
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DNA degradation is characteristic of end-stage
processes of Cd-induced endothelial cell death
In contrast to the flow cytometry-based analyses of
Annexin V/PI stainings, measurement of DNA content in
Cd-treated cells suggests a necrotic outcome (Fig. 6).
Inhibition of Cd-induced DNA degradation was achieved
by the stable knock-down of p53 as these cells were
unaffected when incubated with 15 lM Cd after 48 and
72 h. Inhibition of DNA degradation by p53 KD was also







endothelial cells are shown in
(a–d). Cd-treated endothelial
cells were incubated either with
the calpain inhibitor or BAPTA
and mitochondrial membrane
potential was assayed using a
JC-1 assay and quantified by
flow cytometry analyses (a, d).
b, c The effects of either p53
KD or BCL-XL OE on
mitochondrial membrane
potential in Cd-treated
endothelial cells. e The first row
shows representative images of
Cd-treated endothelial cells
(48 h) stained with MitoTracker
Red and the second row shows
magnifications indicated by the
corresponding white boxes. All
experiments were performed in
triplicates and were repeated at
least three times. Results depict
the mean ± standard deviation.
Asterisks indicate significant
differences compared to the
corresponding (*p\ 0.05;
**p\ 0.01, ***p\ 0.001) and
hash signs indicate significant
differences between the groups
(#p\ 0.05; ##p\ 0.01)
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visible after treatment with 30 lM Cd, despite the effect
only being significant after 48 h (with a non-significant
trend observed after 72 and 96 h; Fig. 6a). Overall, no
inhibitory effect on Cd-induced DNA degradation could be
observed after the pre-incubation with the calpain inhibitor
and the autophagy inhibitor (Supplemental Material, Fig-
ure S7 A, B). Moreover, the pre-incubation of Cd-treated
cells with the Ca2? -Mg2? -dependent endonuclease inhi-
bitor Aurintricarboxylic acid (ATA) does not abolish the
progressive DNA degradation (Supplemental Material,
Figure S8A). However, incubation with the extracellular
Ca2? chelator EGTA prevents Cd-induced DNA degrada-
tion completely (Supplemental Material, Figure S8B).
Figure 6b depicts images of stained cell nuclei of control
and Cd-treated cells after 48 h of incubation. Control cells
show intact cell nuclei containing DNA, whereas the nuclei
of Cd-treated cells show reduced DNA content to almost
complete degradation.
Cd induces the permeabilization of the plasma
membrane and release of LDH
Further confirmation of necrosis as the final outcome of
Cd-induced endothelial cell death is the permeabilization
of the plasma membrane, shown by a massive LDH release
and through scanning electron microscopic-images
(Fig. 7). LDH release induced by 15 lM Cd could be
significantly suppressed by inhibition of calpain activity,
3MA incubation, p53 KD and the combination of the cal-
pain inhibitor with 3MA. LDH release induced by 30 lM
Cd is inhibited neither by the previously mentioned inhi-
bitors nor by a knock-down of p53. Furthermore, a
combination of p53 KD and the individual inhibitors was
not effective in inhibiting membrane permeabilization.
However, the combined treatment of p53 KD endothelial
cells with the calpain inhibitor and 3MA completely
abolishes LDH release in cells treated with 15 lM Cd and
reduces the amount of LDH released from cells treated
with 30 lM Cd to below 21 % of the control level
(Fig. 7a). To illustrate the Cd-induced effects on the
endothelial cell surface, scanning electron microscopic
images were taken and are depicted in Fig. 7b. Shown are
wild-type endothelial cells (CTRL) treated with Cd and
p53 KD cells incubated with the calpain inhibitor and
3MA. Untreated cells show a flattened shape with an intact
plasma membrane and the location of the nucleus is clearly
visible. CTRL cells treated with 15 lM Cd exhibit blebs of
different size on their surface (labelled with stars) and in
addition several leaks in the plasma membrane (labelled
with arrows). Moreover, shrinkage of these cells is
observable. In contrast, p53 KD cells incubated with the
calpain inhibitor and 3MA, and treated with 15 lM Cd are
completely intact. Wild-type cells incubated with 30 lM
Cd exhibit a large number of blebs of different sizes (la-
belled with stars) and the plasma membrane appears to be
completely disintegrated (labelled with stars). As expected
from the results of the LDH assay, p53 KD cells incubated
with the calpain inhibitor and 3MA and treated with 30 lM
Cd showed a slight detachment from the surface and only a
few small holes in the membrane (Fig. 7b).
Discussion
The chelating agents EGTA and EDTA (ethylenedi-
amineteteaacetic acid) which are clinically applied for the
treatment of metal intoxications clearly reduce Cd-induced
DNA degradation in a concentration-dependent manner by
Fig. 4 Cd-induced lysosomal membrane permeabilization and eIF2
alpha phosphorylation. Flow cytometry-based quantification of LMP
was performed in endothelial cells treated with 15 and 30 lM Cd for
72–96 h. The effect of the p53 KD on Cd-induced LMP is depicted in
(a). Western Blot-based analyses of eIF2 alpha phosphorylation in
endothelial cells after Cd treatment is depicted (b). To compensate
unequal protein loading, the Ponceau staining of membranes as well
as the GAPDH expression is shown and the ratio between specific
signal intensity and protein loading (GAPDH) was calculated and
depicted. All experiments were performed in triplicates and were
repeated at least three times. Results depict the mean ± standard
deviation. Asterisks indicate significant differences compared to the
corresponding control (*p\ 0.05; **p\ 0.01) and hash signs
indicate significant differences between the groups (##p\ 0.01)
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forming extracellular complexes with the metal ion,
thereby hindering the cellular uptake of Cd. [45] Once
taken up by cells, Cd is known to cause DNA damage as
already proven in different cell types such as liver cells [46,
47], fibroblasts [48], lung cells [49], and epithelial cells
[50]. Similarly, endothelial cells are also sensitive to Cd-
induced DNA damage as demonstrated by our previous
data showing an increase in the expression of the DNA
Fig. 5 Cd treatment results in
apoptotic as well as necrotic cell
death in endothelial cells.
Endothelial cells were treated
with Cd as indicated for 72 and
96 h and the amount of necrotic
as well as apoptotic cells were
quantified using Annexin V/PI
stainings and flow cytometry-
based analyses (a). The cell
death inhibitory effect of the
calpain inhibitor (b), p53 KD
(c), BCL-XL OE (d), autophagy
inhibition (e) and of 2APB (f) is
also depicted in this figure. All
experiments were performed in
triplicates and were repeated at
least three times. Results depict
the mean ± standard deviation.
Asterisks indicate significant
differences compared to the
corresponding control
(*p\ 0.05; **p\ 0.01,
***p\ 0.001) and hash signs
indicate significant differences
between the groups (#p\ 0.05;
##p\ 0.01; ###p\ 0.001)
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damage response protein p53 [29] and the latest data
showing a pronounced amount of Comet-positive cells
after 12 h of Cd treatment. Interestingly, the extent of
damage is comparable between 15 and 30 lM Cd, although
the number of dead cells is significantly higher after
treatment with 30 lM Cd. Furthermore, the involvement of
DNA damage and p53 in Cd-induced cell death signalling
is shown by the inhibition of cell death (and the preser-
vation of proliferation after Cd treatment, Supplemental
Material, Figure S3 A, B) after the knock-down of p53.
This demonstrates that Cd causes DNA damage in
endothelial cells even at lower concentrations leading to
cell death with the involvement of p53.
In addition to the induction of DNA damage, Cd treat-
ment of endothelial cells induces a rapid and substantial
increase in intracellular Ca2? concentration within 6 h.
Ca2?, as a universal intracellular messenger, influences a
wide range of cellular processes (such as cell death sig-
nalling) when the concentration is elevated in the cytosolic
compartment [51, 52]. Cytosolic Ca2? increase is accom-
plished by either uptake from the extracellular space or
release from intracellular Ca2? stores such as the ER and
the mitochondria. 2APB, a critically discussed blocker of
Ca2? release from the ER, reduces Cd-induced cytosolic
Ca2? concentration but simultaneously inhibits both cel-
lular Cd uptake and Cd-induced cell death significantly.
Moreover, chelation of extracellular Ca2? by EGTA pro-
tects endothelial cells from Cd-induced cell death. Ca2?
concentration showed no link to p53-dependent DNA
damage signalling. Another indication of the release of
Ca2? from the ER through Cd treatment is the fact that the
over-expression of BCL-XL—an anti-apoptotic BCL-2
family member located in the ER membrane—is able to
inhibit the increase of cytosolic Ca2? concentration in
endothelial cells. However, BCL-XL OE did not effec-
tively prevent endothelial cell death following Cd
incubation. Withe and Li et al. confirmed this hypothesis
by providing evidence of a regulation of the inositol
trisphosphate receptor (InsP3R) by BCL-XL through direct
interaction to increase apoptosis resistance [53]. Trans-
mission of the cell death signal from Ca2? is mediated by a
family of Ca2?-dependent non-lysosomal cysteine pro-
teases known as calpains [54]. Interestingly, inhibition of
calpain activity reduces intracellular Ca2? concentration
significantly at low Cd concentrations. Although an
involvement of autophagy in Cd-induced endothelial cell
death is already proven [43], no interplay between
increased cytosolic Ca2? and autophagy could be detected.
The complex signalling pathway is extended by an
involvement of the mitochondria and a variety of factors
influencing mitochondrial function [29]. Depolarisation of
mitochondria as well as the simultaneous loss of mito-
chondrial mass certainly occurs late in the Cd-induced cell
death process (after 48 h). Similarly to p53-mediated cell
death in neuronal cells [55], Cd toxicity leads to mito-
chondrial depolarisation through p53, which was reduced
Fig. 6 Cd treatment of
endothelial cells provokes
complete DNA degradation.
Endothelial cells were treated
with 15 and 30 lM Cd for 48
and 72 h and the cellular DNA
content was quantified in
permeabilized cells using PI
staining and flow cytometry-
based analyses. The effect of
p53 KD on Cd-induced DNA
degradation is shown in (a).
b Representative images of the
PI stained endothelial nuclei
after Cd treatment for 48 h. All
experiments were performed in
triplicates and were repeated at
least three times. Results depict
the mean ± standard deviation.
Asterisks indicate significant
differences compared to the
corresponding control
(*p\ 0.05; **p\ 0.01,
***p\ 0.001) and hash signs
indicate significant differences
between the groups (#p\ 0.05;
##p\ 0.01)
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by the p53 KD. Since outer membrane permeabilization is
weakly inhibited by BCL-XL OE, Bax activation is argu-
ably involved in mitochondrial depolarisation.
Additionally, Cd-induced mitochondrial depolarisation is
also indirectly induced by calpain activation (as already
shown in endothelial cells [55]) as well as directly through
elevated Ca2? levels as indicated by the limited inhibitory
effect of intracellular Ca2? chelation. Lastly, the close
Fig. 7 Cd induced membrane permeabilization and LDH release.
a The analyses of Cd-induced LDH release from endothelial cells into
the cell culture supernatant as well as the effects of inhibitors (calpain
inhibitor and 3MA) and p53 KD and also their combined effect.
Representative scanning electron microscopic images of wild-type
endothelial cells treated with Cd and p53 KD cells pre-incubated with
the calpain inhibitor and 3MA treated with Cd are shown (stars
indicate membrane blebs and arrows mark holes in the plasma
membrane) (b). All experiments were performed in triplicates and
were repeated at least three times. Results depict the mean ± standard
deviation. Asterisks indicate significant differences compared to the
corresponding control (ctrl; *p\ 0.05; **p\ 0.01, ***p\ 0.001),
hash signs indicate significant differences compared to the control
group without the inhibitor or KD (CTRL; #p\ 0.05; ##p\ 0.01;
###p\ 0.001) and section signs indicate significant differences as
between the p53 cells without the inhibitor and p53KD cells with the
inhibitor (§§p\ 0.01)
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proximity between ER cisternae and the mitochondria
allows for local Ca2? oscillation into mitochondria [56].
All these factors ultimately lead to a central element in
apoptosis, which is signal transduction through caspases,
known as apoptosis executors. In the case of Cd-treated
endothelial cells we have previously shown that caspase-3
is cleaved, but Cd inhibits its activity [29]. Therefore, the
apoptotic signalling is halted at this point, underpinned by
unchanged intracellular ATP concentration (Supplemental
Material, Figure S2).
Ca2? imbalance and calpain activation not only lead to
mitochondrial signalling but also result in the initiation of
Fig. 8 Schematic representation of Cd-induced signalling pathways in
endothelial cells. After uptake of Cd in endothelial cells [possibly
through divalent metal transporter 1 (DMT-1)] the cytosolic Ca2?
concentration rises. Besides being taken up from the extracellular space,
Ca2? could also originate from the ER. Redirection of the signal to the
mitochondria could take place directly by Ca2? or also indirectly by the
activation of calpains. Forwarding of the apoptotic signalling from the
mitochondria occurs via the cleavage of caspase-3, but the apoptotic
signal is halted at this point as Cd treatment is known to simultaneously
inhibit caspase-3 activity. Alongside affecting the mitochondria, Cd
treatment impairs also the ER function and induces ER stress (shown by
UPR). Cd-induced ER stress may stop protein synthesis via eIF2 alpha
phosphorylation and also induce autophagic signalling, potentially as a
survival mechanism. An additional target of Cd-induced toxicity in
endothelial cells is cellular DNA. Cd-induced DNA damage results in
upregulation of the DNA damage response protein p53, which in turn is
shown to influence mitochondrial membrane potential. The central
organelle in Cd-induced toxicity is the lysosome, as Cd-induced death
signals from the mitochondria, the ER and p53 are finally ‘‘merging’’ at
the lysosome, inducing LMP. LMP induction is in consequence
responsible for complete DNA degradation and also for plasma
membrane permeabilization and therefore ultimately for the execution
of necrosis in Cd-treated endothelial cells although apoptotic as well as
autophagy signals are triggered as well
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the UPR and induce ER stress, indicated by the phos-
phorylation of eIF2 alpha. Phosphorylation of eIF2 alpha
disables initiation of translation and thereby inhibits the
production of novel unfolded proteins to reduce ER
stress. If this protective feedback loop fails, apoptotic
signalling is induced—likely, once again, via the mito-
chondria [57]. Importantly, the PERK-eIF2 alpha
complex is responsible for the up-regulation of Atg12 and
thereby induces autophagosome formation. The induction
of autophagy signals by Cd treatment, shown by an
increased LC3 II/LC3 I ratio [43] as well as cell death
protection through 3MA incubation, might therefore be
triggered by UPR and eIF2 alpha phosphorylation.
However, autophagy is inhibited since Cd treatment of
endothelial cells provokes lysosomal membrane perme-
abilization (LMP) [43].
Lysosomes are known as ‘‘suicide bags’’ indicating their
role in both cell death mainly through necrosis but also in
survival mechanisms in the case of autophagy [58]. As
previously described, Cd-induced LMP provokes the
release of nucleases triggering complete DNA degradation,
as well as proteases and lipases causing permeabilization of
the plasma membrane [43]. Previously, BCL-XL OE
demonstrated a stabilizing effect on LMP which suggests
the involvement of the mitochondria [43]. An explanation
of this effect could be the fact that BCL-XL attenuates
BAX activity, a pro-apoptotic protein which is known to
induce LMP. Moreover, as BCL-XL is also present in the
ER-membrane, an involvement of this organelle in LMP
cannot be excluded. Lastly, we were able to provide a
connection between a DNA damage-induced increased
expression of p53 and LMP, as the knock-down of p53
rescues cells from Cd-induced LMP, which is already
shown in myeloid leukaemic cells [59]. The signalling
cascade from increased p53 protein levels to LMP is fur-
ther confirmed by the protection of DNA degradation and
the inhibition of plasma membrane rupture by p53 KD. In
contrast to data from neuronal cells by Villalpando
Rodriguez et al. [60], in endothelial cells no connection
between calpain activation, LMP induction and DNA
degradation could be observed. However, an inhibition of
calpain activity inhibits cell membrane permeabilization
and preserves proliferation (Supplemental Material, Fig-
ure S4 A, B), possibly through an as yet unknown
mechanism. Comparable to the inhibition of calpain
activity and the knock-down of p53, the disruption of
autophagy signals also inhibits plasma membrane perme-
abilization. Remarkably, an inhibition of apoptotic
signalling (by p53 KD and inhibition of calpain activity)
combined with autophagy (by using 3MA) was able to
completely prevent necrotic cell death induced by 15 lM
Cd, and to significantly reduce the number of necrotic cell
deaths induced by 30 lM Cd.
In conclusion, although necrosis is commonly known as
an accidental non-regulated death process, Cd-treated
endothelial cells present a highly regulated and complex
cell death signalling mechanism which involves a variety
of different cell organelles. Apoptotic and autophagy sig-
nals induced through Cd toxicity culminate in necrosis
(Fig. 8) and can be prevented by the inhibition of all
activated signalling pathways. In summary, our work
supports the growing body of evidence of the existence of a
highly regulated form of necrosis, as recently reviewed by
Vanden Berghe et al. [61].
Study limitations
The present study is based on several hypotheses, which
limit the extensibility of the observed results to the situa-
tion in humans. A central limitation is that all observations
made are based on an in vitro cell culture model including
the chosen Cd concentrations, which are not necessarily
applicable to the situation in humans. Cd-concentrations
chosen are based on studies by Abu-Hayyeh et al. [6] who
reported on the occurrence of up to 20 lM of Cd in the
aortic wall of chronic smokers, and a study by Bergstro¨m
et al. reporting up to 50 fold increased Cd concentrations in
the vascular intima compared to the blood stream. [62].
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